PANCREAZE 4200 UNT / 17,500 UNT / 10,000 UNT Delayed Release Oral Capsule
RxNorm 968937
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 968937 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PANCREAZE 4200 UNT / 17,500 UNT / 10,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 17500 UNT / lipase 4200 UNT / protease 10000 UNT Delayed Release Oral Capsule [Pancreaze]
(Atom ID: 12361235)
SY
Synonym (SY):
Pancreaze 4 (amylase 17,500 UNT / lipase 4200 UNT / protease 10,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845236)
SY
Synonym (SY):
Pancreaze 4 (amylases 17,500 UNT / lipase 4200 UNT / endopeptidases 10,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845237)
PSN